What you need to know • Increasing rates of adult tonsillitis affect quality of life for patients and put pressure on health services through repeated primary care consultations and hospital admissions with complications
In many, tonsillitis is self-limiting and of relatively short duration. A subset of patients suffers from recurrent debilitating episodes, with impaired daily functioning and absence from work. 1 Adult tonsillitis places a substantial burden on healthcare resources. Costs include primary care consultations, medical treatment, hospital admissions, and treatment of potentially life threatening complications. [1] [2] [3] There are three approaches to the management of tonsillitis: conservative (wait and watch), antibiotics, or tonsillectomy. Tonsillectomy provides definitive treatment for recurrent tonsillitis and was performed on more than 17 000 adult patients in England in 2014-2015. 4 Currently there is uncertainty around the severity of disease at which it is cost effective to perform tonsillectomy on adults with recurrent tonsillitis, as compared with conservative management.
What is the evidence of uncertainty? Search strategy and study selection
We searched Medline, Embase, and the Cochrane Library using the terms "tonsillitis" or "tonsillectomy" or "pharyngitis. " We included studies that involved adults and were published in English between 1996 and February 2017 (table 1⇓) . We found Cochrane reviews comparing antibiotics with placebo, and comparing tonsillectomy with watchful waiting. We also found a review of qualitative outcomes in tonsillectomy, two retrospective studies investigating complications of tonsillectomy, a cross-sectional study of the complications of tonsillitis and tonsillectomy rates, and a small cohort study observing economic outcomes pre and post tonsillectomy.
In the UK, Clinical Commissioning Groups have labelled tonsillectomy as a "relatively ineffective intervention." 2 Since the CCG reports were published, a subsequent change in attitudes towards surgery has led to a steep decline in the rates of tonsillectomies in recent years. 2 10 This reduction in the number of operations has, however, been paralleled by a substantial rise in admissions for tonsillitis and its complications. 2 In this article, we present evidence on the effectiveness of antibiotics and of tonsillectomy, and also the associated costs and complications.
Antibiotics
Antibiotics are frequently prescribed for tonsillitis in primary care. 1 A recent Cochrane systematic review of 27 trials (12 835 cases of sore throat) showed that, at day three of the illness, antibiotics reduced symptoms of sore throat, (risk ratio 0.68; 95% confidence interval 0.59 to 0.79). The incidence of peritonsillar abscess was reduced in comparison with the placebo group (risk ratio 0.15, 95% confidence interval 0.05 to 0.47). 5 The ability to draw on these findings is limited by the lack of subgroup analysis of tonsillitis in the sore throat cases. Further, these modest benefits have to be balanced against side effects, the emergence of antibacterial resistance, and costs.
Tonsillectomy Benefits
A Cochrane review 6 published in 2014 identified two randomised controlled trials from Finland comparing tonsillectomy and watchful waiting in adults. The studies did not report on antibiotic use. There were 3.6 fewer (95% confidence interval 7.9 to 0.70 more) episodes of sore throat within six months of surgery, equating to 10.6 fewer sore throat days (95% confidence interval 5.8 to 15.8). Absenteeism in the surgery arm was not substantially reduced (3.3 days, 95% confidence interval −7.7 to 1.1). Limitations included the short duration of follow-up, statistical heterogeneity, and omission of most postoperative complications from the analysis.
A systematic review concerning the impact of adult tonsillectomy on quality of life outcomes identified eight retrospective cohort studies (708 pooled participants). Several studies reported low response rates (<50%). Outcome measures included generic (short form survey) and specific postsurgical quality of life measures (Glasgow Benefit Inventory). Tonsillectomy was considered likely to improve overall quality of life, particularly patients' physical and general health. 7 
Costs
The direct healthcare costs of an adult tonsillectomy are reflected in the procedure tariff: £1079 in the UK, $3832 in the United States. 8 Tonsillectomy is a painful procedure that requires an average of 14 days off work, 11 with associated costs of lost productivity. Only one small US study (83 adults) assessed the overall economic impact of adult tonsillectomy; it showed a breakeven point of 2.3 years after the procedure through reduced costs, both medical and work related, of tonsillitis. 3 Additionally, patients can suffer complications following tonsillectomy. The commonest adverse event is postoperative haemorrhage, which can require re-operation. A review of complications of adult tonsillectomy from the two largest and most recent North American cohort studies (collectively 42 000 operations) showed a postoperative haemorrhage rate of 6.37% (2308/36 210), 8 re-operation rates for haemorrhage of 1.54% (558/36 210) 8 and 3.2% (189/5968), 9 and a mortality rate of 0.03% (2/5968). 9 The total healthcare costs escalated to an added 60% in the case of re-operation. 8 Healthcare providers should also consider the costs of recurrent tonsillitis and complications if a conservative approach is adopted. A study extracted English Hospital Episode statistics all age data and showed that the overall tonsillectomy rate fell from 159 per 100 000 in 1991 to 89 per 100 000 in 2011 (44% reduction), while the contemporaneous admissions for tonsillitis, peritonsillar abscess, and retro or parapharyngeal abscess rose by 310% (94 per 100 000), 31% (3 per 100 000), and 39% (2 per 100 000), respectively. The use of bed day occupancy as a surrogate for cost implied that the rising rates for sore throat related admissions negated the savings from the decline in tonsillectomy over the decade. 2
Is ongoing research likely to provide relevant evidence?
We searched the Current Controlled Trials Register, the metaRegister of Controlled Trials, and the US Government Clinical Trials Register on 7 February 2017 using the search terms "tonsillitis" or "pharyngitis" or "tonsillectomy." We found one multicentre randomised controlled trial that is currently recruiting patients and is expected to complete in 2019. The National Trial of Tonsillectomy In Adults in the UK (UKCRN ID 17530, www.NATTINA.com) 12 aims to assess the clinical and cost effectiveness of tonsillectomy compared with conservative management (deferred surgery) in 510 adult participants with recurrent tonsillitis. The primary outcome measure is the number of sore throat days over a 24 month period.
What should we do in light of the uncertainty?
The label of a "relatively ineffective intervention" has undoubtedly affected referrals for tonsillectomy. Recent qualitative work demonstrates that general practitioners feel pressured to reduce tonsillectomy referral rates and that many patients perceive a barrier to the treatment they desire. 10 New UK guidelines from the Royal College of Surgeons of England for adult tonsillectomy were published in 2016 13 but are essentially unchanged since the 2010 Scottish Intercollegiate Guidelines Network guidelines, as no further evidence is available (box 1). The referral guideline for surgery on the basis of the frequency and duration of recurrent sore throats only extrapolates from childhood evidence, and evidence is needed on clinical and cost effectiveness in adults. 14 Assess patients for the frequency of episodes and severity of symptoms and their impact on quality of life. Discuss potential risks and likely benefits of either approach to enable making a shared decision (table 2⇓) .
Box 1: Recommended indications for consideration of tonsillectomy for recurrent acute sore throat in adults, based on Scottish Intercollegiate Guidelines Network (SIGN) guidelines
Sore throats are due to acute tonsillitis The episodes of sore throat are disabling and prevent normal functioning Seven or more well documented, clinically significant, adequately treated sore throats in the preceding year, or five or more such episodes in each of the preceding two years, or three or more such episodes in each of the preceding three years. • For most people tonsillitis will resolve with no need for medications or surgery. Your doctor might advise waiting for a period of time as symptoms improve spontaneously, or they might recommend antibiotics if your symptoms are severe.
Recommendations for future research
• Tonsillectomy might be considered if you have several episodes of tonsillitis in a year and they affect your daily functioning.
• Tonsillectomy is effective in reducing episodes of sore throat. However the surgery is associated with complications and costs. Discuss these with your doctor to decide your preferred approach.
Education into practice
• Do you routinely ask your patient about the effect of symptoms of tonsillitis on their life and work?
• Have your compared your own tonsillectomy referral practice with other practitioners?
How patients were involved in the creation of this article
We discussed an early draft of this paper with three patients with tonsillitis. They stressed the importance of considering the severity of tonsillitis episodes and their impact on their life and work. With their comments we highlighted the impact of tonsillitis on quality of life. Evidence supports the benefit of tonsillectomy over watchful waiting Adults meeting SIGN criteria for the number of episodes of tonsillitis (see box 1)
Explain the lack of certainty about benefit of tonsillectomy over watchful waiting, guiding the patient in making a decision Adults not meeting SIGN criteria, but who have a high symptom burden
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